Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate vs UDCA in Newly Diagnosed Primary Biliary Cholangitis
NCT06591455Phase 1Completed
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of fenofibrate in primary biliary cholangitis (PBC) (2 arms). Primary endpoint: Percentage of patients with biochemical response at 6 months. Started Sep 2024; status: completed.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT06591455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06591455.